Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2024/12/03 | Phase 2 | Recruiting | |||
2022/03/18 | Not Applicable | Not yet recruiting | |||
2019/04/24 | N/A | UNKNOWN | Xijing Hospital | ||
2019/03/27 | Phase 4 | Not yet recruiting | |||
2017/11/14 | Phase 2 | Withdrawn | |||
2016/10/04 | Phase 2 | UNKNOWN | |||
2016/09/16 | Phase 4 | UNKNOWN | Hebei Medical University Fourth Hospital | ||
2016/04/15 | Phase 2 | UNKNOWN | |||
2015/11/24 | Phase 3 | Completed | 307 Hospital of PLA | ||
2015/10/23 | Phase 2 | Withdrawn | Guangxi Medical University |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Pirarubicin Hydrochloride for Injection | 国药准字H10930105 | 化学药品 | 注射剂(冻干) | 2/12/2020 | |
Pirarubicin Hydrochloride for Injection | 国药准字H20045983 | 化学药品 | 注射剂 | 6/3/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.